| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
- |
| Employees |
254 |
| Revenues (TTM) (Millions $) |
43,094 |
| Net Income (TTM) (Millions $) |
8,296 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
1,348 |
Business Description
GlaxoSmithKline (GSK) is a British multinational pharmaceutical company that was formed in December 2000 by the merger of Glaxo Wellcome plc and SmithKline Beecham plc. It is headquartered in London, United Kingdom and has operations in more than 150 countries with a presence in both developed and developing economies. The company specializes in the discovery, development, manufacturing, and marketing of prescription drugs, vaccines, over-the-counter (OTC) medicines, and health-related consumer products.
The companyes portfolio is focused on 3 main areas: Pharmaceuticals, Vaccines and Consumer Healthcare. GSKes Pharmaceutical segment offers a wide range of drugs that aim to cure, treat or prevent diseases in different therapeutic areas like cancer, respiratory, cardiovascular and metabolic diseases. Some of the most popular drugs that they produce include Advair, Flovent, Augmentin, Tivicay and Relvar/Breo. The Vaccines segment offers a broad range of preventive vaccines for infectious diseases like meningitis, hepatitis A and B, HPV and flu. Finally, the Consumer Healthcare segment provides OTC medicines, vitamins, supplements, and oral care products such as Aquafresh and Sensodyne.
GSK employs approximately 95,000 people worldwide, with a diverse mix of ethnicities, cultures, and backgrounds. Diversity and inclusion are a key focus for the company, and they have established several programs to promote gender equality, LGBTQ+ rights, and provide equal opportunities for underrepresented communities.
In recent years, GSK has made several acquisitions and divestitures to streamline its operations, including the exit of their oncology business, the acquisition of Novartis' consumer healthcare unit, and the formation of a joint venture with Pfizer for their consumer healthcare business. The company has also invested heavily in research and development to deliver innovative products to the market. In 2020, GSK invested approximately e3.6 billion in R&D, with a focus on disease areas such as HIV/AIDS, respiratory, and oncology.
As a global healthcare leader, GSK has been recognized for its commitment to sustainability and corporate social responsibility. The company has set ambitious targets to reduce its environmental impact, including pledging to be carbon neutral by 2050. GSK has also established various programs focused on improving global health and access to healthcare through initiatives like its global partnership with Save the Children to protect children from preventable diseases.
Overall, GlaxoSmithKline is an innovative pharmaceutical company that is dedicated to developing and delivering innovative medicines and products that improve the health and well-being of people worldwide. Through its commitment to sustainability, diversity, and social responsibility, the company aims to make a positive impact on the world.
Company Address: 79 New Oxford Street London 0
Company Phone Number: 8047 5000 Stock Exchange / Ticker: NYSE GSK
|
51.61 %